What is Tirzepatide and How Does It Work?
Tirzepatide is an FDA-approved medication developed by Eli Lilly, prescribed under the brand names Mounjaro (for Type 2 Diabetes) and Zepbound (for chronic weight management). It functions as a dual-hormone receptor agonist, targeting two key pathways:
- GLP-1 (Glucagon-like peptide-1): Slows gastric emptying, reduces appetite, and stimulates insulin secretion.
- GIP (Glucose-dependent insulinotropic polypeptide): Works synergistically with GLP-1 to enhance glycemic control and increase lipid metabolism.
Clinical Reconstitution Math
While commercial pens are pre-dosed, utilizing lyophilized or compounded Tirzepatide requires exact dosing math to safely follow the standard clinical titration schedule (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg).
A Practical Example
Consider a patient with a 10mg vial of Tirzepatide. They add 1mL of Bacteriostatic Water to the vial. Their desired starting dose is 2.5mg.
Step 1: 10mg ÷ 1mL = 10mg per mL.
Step 2: (2.5mg ÷ 10mg/mL) × 100 = 25 Units.
The patient would draw the U-100 syringe to the "25" tick mark to administer exactly 2.5mg.